A new generation of anti-obesity pills billed as cheaper and more convenient alternatives to weight-loss injections may impose overwhelming costs on the NHS, experts have warned. As many as 12 ...
Pharmaceutical Technology on MSN
Raising the bar: can higher drug spending in the UK deliver for pharma and patients?
The UK considers raising NICE’s cost-effectiveness threshold, testing the balance between funding innovation and conserving NHS budget.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback